Brugada syndrome (BrS) is one of the main inherited arrhythmia syndromes causing
ventricular fibrillation (VF) and sudden cardiac death in young to middle-aged men …

Abstract Aims Brugada syndrome (BrS) is associated with an increased risk of sudden
cardiac death due to ventricular tachycardia/fibrillation (VT/VF) in young, otherwise healthy …

Abstract Background Brugada syndrome (BrS) is an inherited arrhythmic disease linked to
SCN5A mutations. It is controversial whether SCN5A mutation carriers possess a greater …

Brugada syndrome is an inherited arrhythmogenic disorder leading to sudden death
predominantly in the 3–4 decade. To date the only reliable treatment is the implantation of a …

Introduction: Risk stratification for lifethreatening arrhythmic events in Brugada syndrome is
not yet established. The aim of the present study was to examine the usefulness of various …

Background There is limited evidence that Brugada Syndrome (BrS) is due to SCN1B
variants (BrS5). This gene may be inappropriately included in routine genetic testing panels …

Background There is limited information on ethnic differences between patients with
Brugada syndrome (BrS) and arrhythmic events (AEs). Objective The purpose of this study …

Brugada syndrome (BrS) is an arrhythmogenic disorder which was first described in 1992.
This disease is a channelopathy characterized by ST-segment elevations in the right …

In 1992, the Brugada brothers published a patient series of aborted sudden death, who were
successfully resuscitated from ventricular fibrillation (VF). These patients had a characteristic …

Abstract The Brugada syndrome (BrS) is a rare heritable cardiac arrhythmia disorder
associated with ventricular fibrillation and sudden cardiac death. Mutations in the SCN5A …